文献速递免疫规划妇幼与学校卫生慢病防控与筛查

以宫颈癌为显著信息的人乳头瘤病毒疫苗接种信息:一项随机对照试验

Cancer-salient messaging for Human Papillomavirus vaccine uptake: A randomized controlled trial.
PubMed 文献 · Vaccine · 2018-03-26

该3臂随机对照试验纳入9-17岁女孩家长762名,比较宫颈癌显著信息、CDC信息与非疫苗对照信息对疫苗信心和接种意愿的影响。结果显示两种信息均未显著改变接种意愿,宫颈癌信息组接种意愿的OR为1.13(95%CI: 0.30, 4.29),CDC信息组OR为1.25(95%CI: 0.66, 2.37)。探索性分析提示基线疫苗信心低的家长中宫颈癌信息可能更有效。

要点

  • 宫颈癌显著信息与CDC信息均未显著提高家长为女孩接种HPV疫苗的意愿。
  • 宫颈癌信息组接种意愿OR=1.13(95%CI: 0.30, 4.29),CDC信息组OR=1.25(95%CI: 0.66, 2.37)。
  • 基线疫苗信心低的家长中,宫颈癌信息可能比CDC信息或对照更有效改变意愿。

核心结论

  • 两种信息均未对接种意愿产生效果,凸显需研究确定成功的HPV疫苗接种信息策略。
  • 探索性分析提示基线疫苗信心为「低」的家长中,宫颈癌框架信息可能比CDC信息或非疫苗对照更有效改变意愿。
  • 未来工作应针对基线疫苗信心为「低」或「中」的群体,他们可能更易改变且更接受疾病显著信息。

研究设计与样本

  • 3臂随机对照试验,招募9-17岁女孩的家长,通过Amazon Mechanical Turk在线招募和调查。
  • 762名参与者完成基线及干预后两次调查。

主要发现

  • 宫颈癌信息组报告接种意愿的比值是对照组的1.13倍(95%CI: 0.30, 4.29)。
  • CDC信息组与对照组接种意愿无统计学显著差异(OR=1.25,95%CI: 0.66, 2.37)。
  • 宫颈癌信息组与对照组、CDC信息组与对照组疫苗信心均有小幅增加,但估计值无统计学显著性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Vaccination with Human Papillomavirus (HPV) vaccine is recommended for 11-12 years-old, but uptake is suboptimal. Current messaging focuses on HPV infection transmission and prevention. Parents and providers are often uncomfortable discussing sexual practices of adolescents, contributing to the delay/refusal of vaccine. We created a cervical cancer-salient message encouraging HPV vaccination, emphasizing disease salience and disease threat, while promoting self-efficacy. We hypothesized this message would have greater effects on vaccine confidence and intent to vaccinate compared to Centers for Disease Control and Prevention (CDC) and non-vaccine control messages. METHODS: A 3-arm randomized trial was conducted. Parents of girls aged 9-17 were eligible for the study. We measured participants' vaccine confidence and intent to vaccinate at baseline and post intervention message. Recruitment and surveys were administered online through Amazon Mechanical Turk. RESULTS: 762 participants completed both surveys. We saw modest increases in vaccine confidence when comparing cervical cancer arm and control arm, and CDC arm and control arm; estimates were not statistically significant. The odds of reporting intent to vaccinate among the cervical cancer message arm were 1.13 times the odds of reporting intent to vaccinate in the control arm (95% CI: 0.30. 4.29). Intent to vaccinate was also not statistically significantly different between CDC message arm and control arm (OR = 1.25, 95%CI: 0.66, 2.37). CONCLUSION: Neither message had effect on intent to vaccinate, highlighting need for research to identify successful messaging strategies for HPV. Exploratory analyses suggest among parents with 'Low' vaccine confidence at baseline, the cervical cancer framed message may be more effective in changing intention than the CDC message or non-vaccine control. Future work should target groups with 'Low' or 'Medium' vaccine confidence at baseline - they may be more amenable to change, and more receptive to disease-salient messaging. CLINICAL TRIAL REGISTRATION: Clinicaltrials.gov, Reference #: NCT03002324.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Porter RM, Amin AB, Bednarczyk RA, et al. Cancer-salient messaging for Human Papillomavirus vaccine uptake: A randomized controlled trial. Vaccine. 2018. PMID: 29599089. doi:10.1016/j.vaccine.2018.01.040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。